|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
|
|---|---|---|---|---|
| Assets | ||||
| Current assets | ||||
| Cash | ||||
| Prepaid expenses | ||||
| Total current assets | ||||
| Deferred offering costs | ||||
| Investments held in Trust Account | ||||
| Total Assets | ||||
| Current liabilities | ||||
| Due to related party | ||||
| Accounts payable | ||||
| Accounts payable and accrued expenses | ||||
| Promissory note - related party | ||||
| Total current liabilities | ||||
| Deferred underwriting fee payable | ||||
| Total Liabilities | ||||
| Commitments and Contingencies (Note 6) | ||||
| Class A ordinary shares, $0.0001 par value; 450,000,000 shares authorized; 5,750,000 shares subject to possible redemption | ||||
| Shareholders’ Equity: | ||||
| Ordinary shares, value | ||||
| Class A Ordinary Shares | ||||
| Class B ordinary shares | ||||
| Addition paid-in capital | ||||
| Retained earnings (accumulated deficit) | ||||
| Total shareholders’ equity | ||||
| Total Liabilities, Ordinary Shares Subject to Redemption and Shareholders’ Equity |
Loading...
